(Press-News.org) (MEMPHIS, Tenn., June 12, 2023) St. Jude Children’s Research Hospital today announced that Victor J. Torres, Ph.D., an internationally renowned microbiologist and immunologist has been selected as the inaugural chair of a new Department of Host-Microbe Interactions. This department will establish a world-leading effort focused on exploring the fundamental biology of the interaction of infectious agendas with the human host. The discoveries made through this new effort will advance our ability to more effectively treat, as well as prevent infectious diseases
“Infectious diseases remain one of the leading causes of death globally for children under the age of five,” James R. Downing, M.D., St. Jude president and CEO, said. “In our FY22-27 strategic plan, we developed a roadmap to establish a world-leading research effort in infectious diseases that affect children. It calls for collaboration and leadership across multiple programs to advance our mission. I’m thrilled that Dr. Torres has taken the helm of this new department to address the challenges of infectious diseases through basic and translational research.”
Torres joins St. Jude from the New York University Grossman School of Medicine, where he was the C.V. Starr Professor of Microbiology and Director of the Anti-Microbial Resistant Pathogens Program. A world leader in microbiology and host-pathogen interactions, Torres’s research efforts have focused on interactions between pathogenic bacteria and the mammalian host, with an emphasis on multidrug-resistant bacteria.
“Dr. Torres’ expertise and leadership will help St. Jude build a world-class center where we can lead the way in innovation and breakthroughs to change the way infectious diseases are identified and treated, leading to the generation of much-needed therapies,” said J. Paul Taylor, M.D., Ph.D., scientific director at St. Jude.
Torres, who starts in July, is actively recruiting world-class investigators to undertake research to learn key information about fundamental biological, molecular and chemical processes of infectious diseases. The Dept. of Host-Microbe Interactions will work closely with the Dept. of Infectious Diseases, led by Octavio Ramilo, M.D., which applies research discoveries in the clinic.
“The opportunity to create a new Department in a world-class institution doesn’t come around every day,” said Torres. “I’m honored to be able to do it at St. Jude, where research and discovery are at the center of the mission, and where there is already a strong foundation in bacterial and viral respiratory research. This is a once-in-a-lifetime opportunity, and I can’t wait to get started.”
Torres earned his Ph.D. in Microbiology and Immunology from the Vanderbilt University School of Medicine, where he also served as a postdoctoral fellow in the Division of Infectious Diseases and the Department of Microbiology and Immunology. Amongst his accolades, Torres is an editor for the American Society of Microbiology’s Infection and Immunity and mBio journals and an associate editor for the American Association for the Advancement of Science’s journal Science Advances. He’s been awarded the Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease fellowship, and has been elected a fellow of the American Academy of Microbiology, a fellow of the American Association for the Advancement of Science, and was the recipient of a 2021 MacArthur Fellowship, often referred to as the “Genius Grant.”
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago.
St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress blog, and follow St. Jude on social media at @stjuderesearch.
St. Jude Media Relations Contact
Michael Sheffield
Desk: (901) 595-0221
Cell: (901) 379-6072
Michael.Sheffield@stjude.org
media@stjude.org
END
Victor J. Torres, Ph.D., named chair of newly formed Department of Host-Microbe Interactions at St. Jude Children’s Research Hospital
2023-06-12
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Digital divide hinders rural innovation, study shows
2023-06-12
UNIVERSITY PARK, Pa. — Cloud-based computing directly contributes to business innovation, but rural businesses lacking sufficient broadband capacity to access cloud services are missing out on their innovation-boosting potential, according to a team of researchers from Penn State and the National Science Foundation. The findings can be used by policymakers and business-support organizations to foster greater opportunities for rural innovation.
“Innovation plays a critical role in keeping businesses competitive and viable, and in turn, healthy businesses are essential to vibrant rural economies. Therefore, we’re interested ...
Penile HIV infection is effectively prevented by antiretroviral treatment
2023-06-12
Of the 38 million people worldwide living with HIV, approximately 700,000 are newly infected men, primarily via sexual transmission. Sexually transmitted HIV infections in exclusively heterosexual men are acquired through the penis. In addition, semen which is produced in the male genital tract (MGT) has been recognized as the primary vector for vaginal and rectal HIV transmission. Notably, the risk of sexual HIV transmission increases with the presence of a concurrent sexually transmitted infection.
For the majority of patients, antiretroviral therapy (ART) rapidly decreases the viral load in blood and semen, ...
Breakthrough in glioblastoma treatment with the help of a virus
2023-06-12
In a recently published manuscript, Howard Colman, MD, PhD, Jon M. Huntsman Presidential Professor of Neuro-Oncology and co-leader of the Neurologic Cancers Disease Center and the Experimental Therapeutics CCSG program at Huntsman Cancer Institute, identified a potential breakthrough in glioblastoma treatment.
Glioblastoma, or GBM, is an aggressive type of brain cancer. According to Colman, this is the most common type of cancerous brain tumor in adults. Standard treatments include radiation and chemotherapy. Unfortunately, typical GBM tumors are often resistant ...
AMA strengthens its policy on protecting access to gender-affirming care
2023-06-12
CHICAGO—The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to protect access to evidence-based gender-affirming care for transgender and gender-diverse individuals.
As political attacks on gender-affirming care escalate, it is the responsibility of the medical community to speak out in support of evidence-based care. Medical decisions should be made by patients, their relatives and health care providers, not politicians.
In the resolution, the AMA committed to opposing any criminal and legal penalties against patients seeking ...
Even with insurance, many patients with diabetes turn to GoFundMe to offset high cost of care
2023-06-12
Abstract: https://www.acpjournals.org/doi/10.7326/M23-0540
URL goes live when the embargo lifts
An analysis of medical crowdfunding campaigns reveals the types of expenses that patients with diabetes may struggle to afford. The data showed that even insured patients with diabetes used GoFundMe to offset the excess costs of treatment beyond insulin, such as uncovered co-pays, indirect care, and alert dogs. The findings are published in Annals of Internal Medicine.
More than 40% of patients with diabetes in the United States have trouble ...
Working hard for money decreases consumers’ willingness to risk their earnings, study shows
2023-06-12
Studies show that consumers believe people who work hard for their money have higher incomes, are more financially literate and are more comfortable taking on prudent financial risk.
Similarly, national survey data used by policymakers to assess the relationship between effortful earning and financial risk-taking also shows a positive correlation between the two.
While, at the population level this may be true, new research from the University of Notre Dame shows that the harder an individual ...
Four-legged robot traverses tricky terrains thanks to improved 3D vision
2023-06-12
Researchers led by the University of California San Diego have developed a new model that trains four-legged robots to see more clearly in 3D. The advance enabled a robot to autonomously cross challenging terrain with ease—including stairs, rocky ground and gap-filled paths—while clearing obstacles in its way.
The researchers will present their work at the 2023 Conference on Computer Vision and Pattern Recognition (CVPR), which will take place from June 18 to 22 in Vancouver, Canada.
“By providing the robot with a better understanding of its surroundings in 3D, it can be deployed in more complex environments ...
Researcher explores vulnerabilities of AI systems to online misinformation
2023-06-12
A University of Texas at Arlington researcher is working to increase the security of natural language generation (NLG) systems, such as those used by ChatGPT, to guard against misuse and abuse that could allow the spread of misinformation online.
Shirin Nilizadeh, assistant professor in the Department of Computer Science and Engineering, has earned a five-year, $567,609 Faculty Early Career Development Program (CAREER) grant from the National Science Foundation (NSF) for her research. Understanding the vulnerabilities of artificial intelligence (AI) to online misinformation is “an important and timely problem to address,” ...
Food-drug interactions could be impactful for some lung cancer patients according to new study in JNCCN
2023-06-12
PLYMOUTH MEETING, PA [June 12, 2023] — New research in the June 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that when alectinib—a safe and effective small molecule kinase inhibitor used to treat some types of advanced lung cancer—was taken with a fuller breakfast, or with lunch, it resulted in significantly higher drug concentrations than when taken with a low-fat breakfast. The researchers, based out of Rotterdam, The Netherlands, evaluated 20 randomized patients who took one of two daily alectinib doses with either low-fat yogurt ...
U.S. consumers judge morality of armed self-protection on case-by-case basis, OSU research shows
2023-06-12
CORVALLIS, Ore. – American consumers use their understanding of gun rights when judging the morality of civilians’ use of guns to protect themselves from crime, and that assessment varies depending on specific scenarios, new research from Oregon State University shows.
The study’s objective was to explore Americans’ understanding of the Second Amendment, the only constitutional right that explicitly entitles individuals to a consumer product, and how that understanding guides which gun-related behaviors are deemed morally acceptable. The authors also examined how recent court rulings and legal and market ...